Nadroparin LMWH

LMF CY216 - LMF CY 216 - LMF CY-216 - CY216 - CY-216 - CY 216 - Fraxiparine - Fraxiparin - Nadroparine

Acute coronary syndrome

All type of patients:  2 trials  - FRAXIS (6days) - FRAXIS (14 days)

nadroparin vs UFH (on top of aspirin)

No demonstrated result

Pulmonary embolism

All type of patients:  3 trials  - European multicentre study - Prandoni sub-group - Thery

Nadroparin vs unfractionated heparin

No demonstrated result

Superficial thrombophlebitis

Superficial thrombophlebitis of the leg :  3 trials  - Titon (nadroparin 0.6ml vs naproxen) - Vesalio - Titon (nadroparin 61.5 IU anti-Xa/kg vs naproxen)

nadroparin vs naproxene

No demonstrated result

nadroparin fixed-dose vs nadroparin weight-adjusted

No demonstrated result

Thrombosis prevention

Abdominal surgery:  1 trials  - EFS

nadroparin vs unfractionated heparin

No demonstrated result

suggested Symptomatic venous thromboembolism (DVT, PE) by 73% (not demonstrated)

See more clinical conditions

Arthroscopy:  2 trials  - KANT (7 days) - KANT (14 days)

nadroparin vs control

No demonstrated result

suggested total VTE and all-cause mortality by 71% (not demonstrated)

nadroparin 14d vs control

No demonstrated result

suggested total VTE and all-cause mortality by 72% (not demonstrated)

Elective hip replacement:  1 trials  - Yoo

nadroparin vs no treatment

No demonstrated result

General surgery:  7 trials  - Balas [40] - Marassi [41] - Kakkar and Murray - EFS - Dahan - Barbui - Eurin

nadroparin vs no treatment

No demonstrated result

suggested asymptomatic DVT by 81% (not demonstrated)

nadroparin vs placebo

No demonstrated result

nadroparin vs unfractionated heparin

No demonstrated result

suggested asymptomatic DVT by 39% (not demonstrated)

suggested Symptomatic venous thromboembolism (DVT, PE) by 75% (not demonstrated)

Hip Fracture:  1 trials  - Sourmelis

nadroparin vs placebo

No demonstrated result

Medical patients:  3 trials  - Fraisse - Mahe - Bergmann

Nadroparin vs placebo

No demonstrated result

Neurosurgery:  1 trials  - Nurmohamed

nadroparin vs placebo

No demonstrated result

Orthopedic surgery:  3 trials  - Yoo - Sourmelis - NPHDO

nadroparin vs no treatment

No demonstrated result

nadroparin vs placebo

No demonstrated result

out of hospital Nadroparin vs standard prophylaxis

No demonstrated result

Patients with immobilization of the lower extremities:  2 trials  - PROTECT (nadroparin) - Kujath

nadroparin vs control

No demonstrated result

suggested Venous thromboembolism by 71% (not demonstrated)

nadroparin vs no treatment

No demonstrated result

Venous thrombosis

All type of patients:  6 trials  - Collaborative European Multicentre - Prandoni et al - Lopaciuk et al - Charbonnier - Lopaciuk - Lopez-Beret

Nadroparin vs acenocoumarol

No demonstrated result

Nadroparin vs unfractionated heparin

No demonstrated result

once daily nadroparin vs twice daily nadroparin

No demonstrated result

See more clinical conditions

Patients with cancer:  1 trials  - Lopez Beret

extended nadroparin vs standard treatment

No demonstrated result